Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.81 | ||
| Change(%) | ![]() | 0.00 | |
| Volume | 204576 | ||
| 12:40 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
-- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business --

Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027--
Enzon Reveals New LNA Targets
-- Data will be presented at upcoming American Association for Cancer Research Meeting--
Enzon Nominates Two New Candidates for its Board of Directors
Enzon Discontinues its Plan to Spin-off its Biotechnology Business
